Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference
Data from DELIVER and ACHIEVE Clinicals Trial to be Presented -- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on ...
NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation
Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.
yogonet16h
SYNOT Group: "Moving ICE to Barcelona was the perfect chance for us to take our presentation to the next level"
Miroslav Valenta and Stanislav Stanev Stanislav Stanev, International Business Development Director (left) and Miroslav ...
Tokio Marine: Re-New Initiative Likely To Create Value
Tokio Marine is a strong buy! Emerging market growth, resilient profitability, and the 'Re-New' initiative drive its ...